ExploreWatchlistsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Total liabilities

Mochida Pharmaceutical Co.,Ltd. (4534)

Market cap
¥113.2B
P/E ratio
11x
A Japanese pharmaceutical company that develops and sells prescription drugs and healthcare products through a network of manufacturing and sales subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 202642,394+44.07%
Mar 31, 202529,426-4.56%
Mar 31, 202430,833-3.82%
Mar 31, 202332,056-7.07%
Mar 31, 202234,493-0.93%
Mar 31, 202134,816-5.45%
Mar 31, 202036,822+8.59%
Mar 31, 201933,909-4.12%
Mar 31, 201835,367-3.11%
Mar 31, 201736,502+11.34%
Mar 31, 201632,783+13.49%
Mar 31, 201528,886

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat